These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16208129)

  • 1. Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy.
    Leon CA; Raij L
    J Hypertens; 2005 Nov; 23(11):1931-7. PubMed ID: 16208129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular bases of diabetic nephropathy].
    Lagranha CJ; Fiorino P; Casarini DE; Schaan BD; Irigoyen MC
    Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):901-12. PubMed ID: 17934656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The link between Glut-1 and hypertension in diabetic nephropathy.
    Gnudi L; Raij L
    Curr Hypertens Rep; 2006 Apr; 8(1):79-83. PubMed ID: 16600163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
    Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
    Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease.
    Miranda-Díaz AG; Pazarín-Villaseñor L; Yanowsky-Escatell FG; Andrade-Sierra J
    J Diabetes Res; 2016; 2016():7047238. PubMed ID: 27525285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
    Castellino P; Shohat J; DeFronzo RA
    Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of renal failure in diabetic nephropathy.
    Marcantoni C; Ortalda V; Lupo A; Maschio G
    Nephrol Dial Transplant; 1998; 13 Suppl 8():16-9. PubMed ID: 9870420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
    Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
    Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiologic mechanisms of early changes in renal hemodynamics in diabetes mellitus].
    Komers R
    Cas Lek Cesk; 1996 Mar; 135(5):135-9. PubMed ID: 8681353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.
    Wolf G
    Eur J Clin Invest; 2004 Dec; 34(12):785-96. PubMed ID: 15606719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide in diabetic nephropathy.
    Prabhakar SS
    Semin Nephrol; 2004 Jul; 24(4):333-44. PubMed ID: 15252773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
    Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy.
    Wang Y; Wang C; Zhang X; Gu HF; Wu L
    Curr Diabetes Rev; 2018; 14(2):149-161. PubMed ID: 28201968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
    Raij L
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy: hemodynamic basis and implications for disease management.
    Noth RH; Krolewski AS; Kaysen GA; Meyer TW; Schambelan M
    Ann Intern Med; 1989 May; 110(10):795-813. PubMed ID: 2653154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the regulation of renal hemodynamic function in diabetic mellitus.
    Cherney DZ; Scholey JW; Miller JA
    Curr Diabetes Rev; 2008 Nov; 4(4):280-90. PubMed ID: 18991597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TGF-beta in pathogenesis of diabetic nephropathy.
    Pantsulaia T
    Georgian Med News; 2006 Feb; (131):13-8. PubMed ID: 16575121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial.
    Fallahzadeh MK; Dormanesh B; Sagheb MM; Roozbeh J; Vessal G; Pakfetrat M; Daneshbod Y; Kamali-Sarvestani E; Lankarani KB
    Am J Kidney Dis; 2012 Dec; 60(6):896-903. PubMed ID: 22770926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.